Saxenda-weight-loss

Saxenda is a prescription medication for weight loss. It is used for people who are overweight or obese and is a form of glucagon-like peptide-1 (GLP-1) receptor agonist. The medication works by increasing feelings of fullness and reducing hunger. Saxenda is injected subcutaneously once a day and is typically used in combination with a low-calorie diet and increased physical activity.

Studies

Studies have shown that Saxenda can lead to significant weight loss and improvement in obesity-related health conditions such as type 2 diabetes and high blood pressure. However, as with all medications, there are potential side effects including nausea, diarrhea, constipation, and headache. It is important to discuss the benefits and risks of using Saxenda with a healthcare provider prior to starting treatment.

Use in obesity and obesity

Liraglutide, also known by its brand name Saxenda, is a medication used for the treatment of obesity and type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist that stimulates insulin production and suppresses appetite, leading to weight loss and improved blood sugar control. Liraglutide is taken once a day, before the first meal, and is used in combination with diet and exercise.

In clinical trials, patients taking liraglutide in combination with diet and exercise lost an average of 5-10% of their body weight, compared to diet and exercise alone. The most common side effects reported in clinical trials are gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Other potential side effects include headache, dizziness, and pancreatitis.

Liraglutide has also been shown to have additional health benefits including improved cardiovascular health and reduced risk of heart disease in overweight or obese individuals, as well as improved liver function in people with non-alcoholic fatty liver disease.

The mechanism by which liraglutide promotes weight loss is thought to reduce hunger and increase feelings of fullness, as well as regulate blood sugar levels. Liraglutide was approved by the U.S. Food and Drug Administration (FDA) in 2014 for the treatment of obesity and type 2 diabetes.

It is important to work with a healthcare provider to determine if liraglutide, or Saxenda, is appropriate for an individual's needs and medical history. A comprehensive weight loss plan that takes into account individual needs and medical history should also be developed.

Liraglutide works by stimulating the release of insulin and suppressing the release of glucagon, two hormones that regulate hunger and metabolism. This leads to improved blood sugar control and decreased food intake, ultimately resulting in weight loss.

In clinical trials, patients taking liraglutide in combination with diet and exercise lost an average of 5-10% of their body weight over the course of 56 weeks. This weight loss was accompanied by improvements in other health markers, such as blood pressure, cholesterol levels, and blood sugar control.

Side effects

Serious side effects reported in patients treated with Saxenda include pancreatitis, gallbladder disease, renal impairment, and suicidal thoughts. Saxenda can also raise heart rate and should be discontinued in patients who experience a sustained increase in resting heart rate.

In clinical trials, the most common side effects observed in patients treated with Saxenda were

nausea
diarrhea
constipation
vomiting
low blood sugar (hypoglycemia), and
decreased appetite.

How can W8MD help?

If you are looking for an experienced weight loss doctor that can discuss if Saxenda might be the right choice for you, please feel free to contact us.

W8MD Weight Loss, Sleep & Medspa Centers

W8MD Weight Loss, Sleep & Medspa Centers is a network of medical centers located in New York, Pennsylvania, New Jersey and surrounding areas that provide comprehensive care for weight loss, sleep disorders, and aesthetic treatments.